Cargando…
The value of ROX index in predicting the outcome of high flow nasal cannula: a systematic review and meta-analysis
BACKGROUND: High flow nasal cannula (HFNC) therapy is widely employed in acute hypoxemic respiratory failure (AHRF) patients. However, the techniques for predicting HFNC outcome remain scarce. METHODS: PubMed, EMBASE, and Cochrane Library were searched until April 20, 2021. We included the studies t...
Autores principales: | Junhai, Zhen, Jing, Yan, Beibei, Cao, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851822/ https://www.ncbi.nlm.nih.gov/pubmed/35177091 http://dx.doi.org/10.1186/s12931-022-01951-9 |
Ejemplares similares
-
Predicting Outcomes of High-Flow Nasal Cannula for Acute Respiratory Distress Syndrome. An Index that ROX
por: Hill, Nicholas S., et al.
Publicado: (2019) -
Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis
por: Yau, Chun En, et al.
Publicado: (2023) -
Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate
por: Goh, Ken Junyang, et al.
Publicado: (2020) -
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure
por: Lemiale, Virginie, et al.
Publicado: (2021) -
Correction to: Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure
por: Lemiale, Virginie, et al.
Publicado: (2021)